VEEV 10-K Annual Report Jan. 31, 2023

VEEVA SYSTEMS INC

10-Ks and 10-Qs

10-Q	Quarter ended Oct. 31, 2024
10-Q	Quarter ended July 31, 2024
10-Q	Quarter ended April 30, 2024
10-K	Fiscal year ended Jan. 31, 2024
10-Q	Quarter ended Oct. 31, 2023
10-Q	Quarter ended July 31, 2023
10-Q	Quarter ended April 30, 2023
10-K	Fiscal year ended Jan. 31, 2023
10-Q	Quarter ended Oct. 31, 2022
10-Q	Quarter ended July 31, 2022
10-Q	Quarter ended April 30, 2022
10-K	Fiscal year ended Jan. 31, 2022
10-Q	Quarter ended Oct. 31, 2021
10-Q	Quarter ended July 31, 2021
10-Q	Quarter ended April 30, 2021
10-K	Fiscal year ended Jan. 31, 2021
10-Q	Quarter ended Oct. 31, 2020
10-Q	Quarter ended July 31, 2020
10-Q	Quarter ended April 30, 2020
10-K	Fiscal year ended Jan. 31, 2020
10-Q	Quarter ended Oct. 31, 2019
10-Q	Quarter ended July 31, 2019
10-Q	Quarter ended April 30, 2019
10-K	Fiscal year ended Jan. 31, 2019
10-Q	Quarter ended Oct. 31, 2018
10-Q	Quarter ended July 31, 2018
10-Q	Quarter ended April 30, 2018
10-K	Fiscal year ended Jan. 31, 2018
10-Q	Quarter ended Oct. 31, 2017
10-Q	Quarter ended July 31, 2017
10-Q	Quarter ended April 30, 2017
10-K	Fiscal year ended Jan. 31, 2017
10-Q	Quarter ended Oct. 31, 2016
10-Q	Quarter ended July 31, 2016
10-Q	Quarter ended April 30, 2016
10-K	Fiscal year ended Jan. 31, 2016
10-Q	Quarter ended Oct. 31, 2015
10-Q	Quarter ended July 31, 2015
10-Q	Quarter ended April 30, 2015
10-K	Fiscal year ended Jan. 31, 2015
10-Q	Quarter ended Oct. 31, 2014
10-Q	Quarter ended July 31, 2014
10-Q	Quarter ended April 30, 2014
10-K	Fiscal year ended Jan. 31, 2014
10-Q	Quarter ended Oct. 31, 2013

PROXIES

DEF 14A	Filed on April 23, 2024
DEF 14A	Filed on May 10, 2023
DEF 14A	Filed on April 27, 2022
DEF 14A	Filed on May 10, 2021
DEF 14A	Filed on Dec. 3, 2020
DEF 14A	Filed on May 12, 2020
DEF 14A	Filed on May 9, 2019
DEF 14A	Filed on May 4, 2018
DEF 14A	Filed on May 9, 2017
DEF 14A	Filed on May 10, 2016
DEF 14A	Filed on May 5, 2015
DEF 14A	Filed on April 25, 2014

TABLE OF CONTENTS

Part I Item 1. Business Item 1A. Risk Factors Item 1B. Unresolved Staff Comments Item 2. Properties Item 3. Legal Proceedings Item 4. Mine Safety Disclosures Part II Item 5. Market For Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases Of Equity Securities Item 6. [reserved]Item 7. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Consolidated Financial Statements and Supplementary Data Note 1. Summary Of Business and Significant Accounting Policies Note 2. Short-term Investments Note 3. Deferred Costs Note 4. Property and Equipment, Net Note 5. Goodwill and Intangible Assets Note 6. Accrued Expenses Note 7. Fair Value Measurements Note 8. Income Taxes Note 9. Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable Note 10. Leases Note 11. Stockholders Equity Note 12. Other Income Note 13. Net Income Per Share Note 14. Commitments and Contingencies Note 15. Revenues By Product Note 16. Information About Geographic Areas Note 17. 401(k) Plan Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B. Other Information Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections Part III Item 10. Directors, Executive Officers and Corporate Governance Item 11. Executive Compensation Item 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder Matters Item 13. Certain Relationships and Related Transactions, and Director Independence Item 14. Principal Accounting Fees and Services Part IV Item 15. Exhibits, Financial Statement Schedules Item 16. Form 10-k Summary

Exhibits

10.15 Data Processing Addendum, dated January 23, 2016, to Value-Added Reseller Agreement, between Registrant and salesforce.com, inc., as amended. 10-K 001-36121 10.17 3/31/2016 10.16 Offer letter, dated February 20, 2015, between Alan V. Mateo and the Registrant. 10-Q 001-36121 10.1 6/8/2016 10.17 Offer letter, dated January 23, 2013, between E. Nitsa Zuppas and the Registrant. 10-Q 001-36121 10.2 6/8/2016 10.18 Ninth Amendment, dated August 11, 2016, to Amended and Restated Value-Added Reseller Agreementdated September 2010, betweenRegistrant andsalesforce.com, inc., as amended. 10-Q 001-36121 10.1 9/8/2016 10.19 2013 Equity Incentive Plan Forms of Notice of Stock Option Grants to Peter P. Gassner. 10-K 001-36121 10.22 3/30/2018 10.20 Offer Letter, dated March 17, 2019, between Tom Schwenger and the Registrant. 10-Q 001-36121 10.1 6/4/2020 10.21 Offer Letter, dated April 19, 2020, between Brent Bowman and the Registrant. 8-K 001-36121 10.1 8/31/2020 10.22 Advisor Agreement, dated September 30, 2022, between Frederic Lequient and the Registrant. 10-Q 001-36121 10.1 12/7/2022 21.1 List of Subsidiaries of Registrant. 23.1 Consent of KPMG LLP, Independent Registered Public Accounting Firm. 31.1 Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended. 31.2 Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended. 32.1 Certification of Chief Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. 1350. 32.2 Certification of Chief Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. 1350.

Customer name	Ticker
Abbott Laboratories	ABT
Becton, Dickinson and Company	BDX
Bristol-Myers Squibb Company	BMY
Eli Lilly and Company	LLY
Johnson & Johnson	JNJ
Merck & Co., Inc.	MRK
Pfizer Inc.	PFE

VEEV 10-K Fiscal year ended Jan. 31, 2023

Exhibits